Phenolic profile and pharmacological propensities of Gynandriris sisyrinchium through in vitro and in silico perspectives

Basit Öğe Kaydı
dc.contributor.authorZengin, Gökhan
dc.contributor.authorMollica, Adrian
dc.contributor.authorAumeeruddy, Muhammad Zakariyyah
dc.contributor.authorRengasamy, Kannan R. R.
dc.contributor.authorMahomoodally, Mohamad Fawzi
dc.date.accessioned2020-03-26T19:55:04Z
dc.date.available2020-03-26T19:55:04Z
dc.date.issued2018
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractGynandriris sisyrinchiwn is a traditionally used medicinal plant, yet there is a dearth of scientific information on its biological potential and polyphenolic profile. In this endeavour, we aimed to assess and compare the biological properties of different extracts (ethyl acetate, methanol, and water) of G. sisyrinchiwn based on enzyme inhibitory effects coupled with docking studies and antioxidant ability together with screening of bioactive compounds. Polyphenolic composition was assessed by determining total phenolic (TPC) and flavonoid (TFC) content as well as individual phenolic compounds by RP-HPLC-DAD. The antioxidant properties were determined by different assays including free radical scavenging (ABTS and DPPH), reducing power (CUPRAC and FRAP), phosphomolybdenum, and metal chelating. The enzyme inhibitory activities of the extracts were evaluated for the first time against cholinesterases, tyrosinase, alpha-amylase, and alpha-glucosidase. Docking studies were performed to elucidate the interactions of phenolic compounds with the enzymes. Results show that the methanol extract exerted better scavenging, reducing, tyrosinase, and alpha-glucosidase inhibitory activities while the less polar ethyl acetate extract showed better phosphomolybdenum and metal chelating activity, AChE, BChE, and alpha-amylase inhibition. The most abundant compounds were apigenin (4224 and 1876 mu g/g extract in the methanolic and ethyl acetate extract, respectively), benzoic acid (1870 mu g/g extract in the methanolic extract), pcoumaric acid (472 mu g/g extract in the methanolic extract), and quercetin (348 mu g/g extract in the methanolic extract). The present findings suggest that G. sisyrinchiwn can be considered as a potential source of bioactive compounds for novel phytopharmaceuticals development in the treatment and/or management of non communicable diseases.en_US
dc.identifier.doi10.1016/j.indcrop.2018.05.027en_US
dc.identifier.endpage337en_US
dc.identifier.issn0926-6690en_US
dc.identifier.issn1872-633Xen_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage328en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.indcrop.2018.05.027
dc.identifier.urihttps://hdl.handle.net/20.500.12395/36847
dc.identifier.volume121en_US
dc.identifier.wosWOS:000437996900038en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE BVen_US
dc.relation.ispartofINDUSTRIAL CROPS AND PRODUCTSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAntioxidantsen_US
dc.subjectTyrosinaseen_US
dc.subjectalpha-glucosidaseen_US
dc.subjectalpha-amylaseen_US
dc.subjectNoncommunicable diseaseen_US
dc.subjectPolyphenolsen_US
dc.titlePhenolic profile and pharmacological propensities of Gynandriris sisyrinchium through in vitro and in silico perspectivesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu